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Three-Dimensional Imaging Core Laboratory of the Endovascular
Aneurysm Repair Trials: Validation of Methodology
Wyss T.R., Dick F., England A., Brown L.C., Rodway A.D., Greenhalgh
R.M. Eur J Vasc Endovasc Surg 2009;38:724-31.
Objective: The aim of this study was to establish and validate a
three-dimensional imaging protocol for the assessment of Computed To-
mography (CT) scans of abdominal aortic aneurysms in UK EVAR trials
patients. Quality control and repeatability of anatomical measurements is
important for the validity of any core laboratory.
Methods: Three different observers performed anatomical measure-
ments on 50 preoperative CT scans of aortic aneurysms using the Vitrea 2
three-dimensional post-imaging software in a core laboratory setting. We
assessed the accuracy of intra and interobserver repeatability of measure-
ments, the time required for collection of measurements, 3 different levels of
automation and 3 different automated criteria for measurement of neck
length.
Results: None of the automated neck length measurements demon-
strated sufficient accuracy and it was necessary to perform checking of the
important automated landmarks. Good intra and limited interobserver
agreement were achieved with three-dimensional assessment. Complete
assessment of the aneurysm and iliacs took an average (SD) of 17.2 (4.1)
minutes.
Conclusions: Aortic aneurysm anatomy can be assessed reliably and
quickly using three-dimensional assessment but for scans of limited quality,
manual checking of important landmarks remains necessary. Using a set
protocol, agreement between observers is satisfactory but not as good as
within observers.
The Anaconda™ AAA Stent Graft System: 2-Year Clinical and Techni-
cal Results of a Multicentre Clinical Evaluation
Ro¨del S.G.J., Geelkerken R.H., Prescott R.J., Florek H.J., Kasprzak P.,
Brunkwall J.on behalf of the ANA 004 study group Eur J Vasc Endovasc
Surg 2009;38:732-40.
Introduction: This study reports the technical and mid-term clinical
results of the second-generation Anaconda™ AAA Stent Graft System
endovascular device for treatment of abdominal aortic aneurysm (AAA). The
design of the Anaconda™ AAA Stent Graft System is characterised by a
three-piece system consisting of two proximal independent saddle-shaped
nitinol self-expandable rings with hooks fixation, zero body support and
vacuum-cleaner tube leg design.
Methods: From July 2002 to April 2005, a total of 61 patients with
AAA were enrolled in a multicentre, prospective, non-randomised con-
trolled design study. All patients received a second-generation Anaconda™Readers can access EJVES articles at http://intl.erupture-free survival; incidence of aneurysm rupture, death from aneurysm
rupture, aneurysm-related death; freedom from aneurysm expansion; free-
dom from Types I and III endoleaks; endograft patency and technical and
clinical success rates.
Results: Successful access to the arterial system was achieved in all
patients. The primary technical success was 59 out of 61 and the primary
assisted technical success was 60 out of 61. All endovascular grafts were
patent without significant twists, kinks or obstructions. Migration was not
observed in any of the grafts. During the first 30-day period, two serious
adverse events (3%), both not related to the procedure, were observed. Nine
patients (15%) needed a secondary intervention; two of these interventions
were related to stent graft (3%). The mean aneurysm sac diameter decreased
significantly from 57 mm pre-operative to 45 mm after 24 months, without
aneurysm growth. There was one Type I endoleak at initial implantation,
which was corrected using a proximal extension cuff. In total, three Type II
endoleaks were still present after 24 months without any signs of aneurysm
growth.
Conclusion: The design features of the second-generation Anacon-
da™ AAA Stent Graft System are effective in the treatment of AAAs on
mid-term evaluation.
Results of Surgical Treatment Compared with Ultrasound-Guided
Foam Sclerotherapy in Patients with Varicose Veins: A Prospective
Randomised Study
Figueiredo M., Arau´jo S., Barros N.Jr., Miranda F.Jr. Eur J Vasc Endovasc
Surg 2009;38:758-63.
Objective:This study aims to compare venous clinical severity scores in
patients with healed venous ulcers due to varicose veins of the lower limbs
(the clinical, etiologic, anatomic, and pathophysiologic data (CEAP) classi-
fication: C5 EpAsPr) treated by saphenous stripping and phlebectomy or by
ultrasound-guided foam sclerotherapy.
Method: Sixty patients were included: 29 underwent saphenous strip-
ping and phlebectomy for varices in saphenous tributaries and 27 were
treated by ultrasound-guided foam sclerotherapy; four cases were lost to
follow-up. The main outcome measure was venous clinical severity scores
(pain, oedema, inflammation, hyperpigmentation and lipodermatosclero-
sis). An ultrasound examination was carried out prior to treatment and 30,
60 and 180 days after the procedure to assess the relative efficacy of the
methods in obliterating the saphenous trunk.
Results: The mean venous clinical severity scores measured before and
after 180 days were as follows: Surgery group – pain: before 1.97 standard
deviation (SD) 0.19, 180 days 0.72 SD 0.53; oedema: before 1.66 SD 0.48,
180 days 0.55 SD 0.63; inflammation: before 1.55 SD 0.63, 180 days 0.72
SD 0.45. Foam sclerotherapy group – pain: before 1.81 SD 0.40, 180 days
0.56 SD 0.51; oedema: before 1.70 SD 0.47, 180 days 0.48 SD 0.64;
inflammation: before 1.67 SD 0.68, after 0.89 SD 0.32. All scores showed
statistically significant reductions in both patient groups. The saphenous
vein had been obliterated, 180 days after treatment, in 78% of the surgery
group, compared with 90% in the foam sclerotherapy group.AAA Stent Graft System. They entered a standard follow-up protocol at
discharge for 3, 6, 12 and 24 months. Follow-up data included survival;
Conclusions: Ultrasound-guided foam sclerotherapy is a safe and
effective option for patients with chronic venous disorders.lsevierhealth.com/journals/ejvs/default.cfm
